iPS Cell Bank Management System for Quality Traceability
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current systems lack a comprehensive management solution for the production, quality control, and distribution of induced pluripotent stem cells (iPS cells) that adheres to regulatory standards, leading to challenges in maintaining and ensuring the quality of these cells throughout their production, stocking, and transportation.
Innovation Solution
A system and method for an iPS cell bank utilizing a cloud-based management system with terminal and server apparatuses that manage the entire lifecycle of iPS cells, including somatic cell acceptance, production, stocking, and transportation, ensuring compliance with quality and safety regulations through precise data management and quality testing.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If a comprehensive management system is implemented to manage the entire lifecycle of iPS cells including somatic cell acceptance, production, stocking, and transportation, then the quality and reliability of iPS cells is improved, but the device complexity and system infrastructure requirements increase
Solution Approach 1:
The management system is divided into multiple functional modules: somatic cell acceptance management, production management, stocking management, and transportation management. Each module handles specific aspects of the iPS cell lifecycle, making the overall complex system manageable and maintainable while ensuring comprehensive quality control at each stage.
Solution Approach 2:
The server apparatus and terminal apparatus are designed to perform multiple functions across different management stages. The system can handle various types of data (donor information, production data, quality test results) and perform diverse operations (registration, tracking, analysis) using a unified platform, reducing the need for separate specialized systems.
2Manufacturing precision
If precise data management and quality testing are performed throughout the iPS cell lifecycle, then the manufacturing precision and quality of iPS cells is improved, but the time and cost of production increase
Solution Approach 1:
The system performs preliminary registration and management of somatic cells before actual iPS cell production begins. Donor information, cell characteristics, and initial quality parameters are captured in advance, allowing production processes to proceed efficiently with pre-validated data, reducing delays during production.
Solution Approach 2:
The management system continuously collects and analyzes quality test results from various stages of iPS cell production. This feedback mechanism allows for real-time monitoring and adjustment of production parameters, ensuring high manufacturing precision while identifying and addressing quality issues promptly to minimize production delays.
3Reliability
If unified management of enormous data related to production management and quality management is implemented, then the reliability and traceability of iPS cells is improved, but the device complexity and data processing requirements increase
Solution Approach 1:
The server apparatus acts as an intermediary between various data sources (terminal apparatuses, laboratories, storage facilities) and the central management system. It consolidates, standardizes, and manages enormous amounts of data from different stages, ensuring reliable traceability while handling data processing requirements through centralized infrastructure.
4Reliability
If strict quality evaluation and regulatory compliance are enforced at each stage, then the reliability of iPS cells for clinical use is improved, but the productivity and speed of bringing iPS cells to market decreases
Solution Approach 1:
The management system enables continuous monitoring and management of iPS cells from somatic cell acceptance through production, stocking, and transportation. Quality evaluation and regulatory compliance checks are integrated into each continuous stage rather than being separate batch processes, maintaining productivity while ensuring strict quality control throughout the entire lifecycle.
Data Source
AI summary
A system for an iPS cell bank includes a terminal and a server. The terminal receives and sends a production request including a desired collection date of a somatic cell and a customer ID to the server. The server stores a collectable date for collecting the somatic cell, a producible period for producing an iPS cell, and a location and a stockable period for stocking the iPS cell; and determines: a collection date based on the desired collection date and the collectable date; a production period based on the collection date and the producible period; an acceptance date of the somatic cell based on the collection date and the production period; a stock location and a stock period based on the production period, the stockable location, and the stockable period; and a shipment date of the iPS cell based on the production period, the stockable location, and the stockable period.